Drug-labels.com

Anuzinc Hc Product Monograph

Updated:
Facts
Status:
Prescription (Rx) Current status: Dormant
Strength:
10 mg / 10 mg
Active ingredients:

Product Monograph - Anuzinc Hc

Adverse effects

Occasionally, patients may experience burning upon application, especially if the anoderm is not intact. Local sensitivity reaction has been rare.

Symptoms and treatment of overdosage

Symptoms: No toxic effects have been reported.

Treatment: In case of accidental ingestion, perform gastric lavage.

For management of a suspected drug overdose, contact your regional poison control centre.

Dosage and administration

Bathe and dry the affected anal area. Then insert one suppository upright into the rectum. Administer 1 suppository of ANUZINC HC in the morning and again at bedtime, and after each bowel movement. Continue this treatment until the acute phase of pain and discomfort passes and the inflammation subsides. Thereafter maintain patient comfort and continue treatment with one daily application after the morning stool

Suppositories are most easily administered in a stooped or squatting position, or while lying on the side with knees flexed. The exertion of a slight bearing down pressure relaxes the anal sphincter which permits painless insertion of the suppository.

Availability of dosage forms

Each ANUZINC HC suppository contains hydrocortisone acetate 10 mg, zinc sulfate monohydrate 10 mg, in a triglyceride base. Non-medicinal ingredients: Methylparaben, propylparaben, hard fat.

ANUZINC HC is available in boxes of 12.

Store between 15 and 30°C. Keep out of reach and sight of children.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02242798

Revision date stated in the text: July 19, 2021

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Anuzinc Hc

Rx or OTC
Prescription (Rx)?
DIN 02242798
Schedule(s) PRESCRIPTION
Active ingredient(s) Hydrocortisone acetate 10 MG, Zinc sulfate 10 MG
Dosage form(s) Suppository
Route(s) of administration Rectal
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C05 Vasoprotectives
      1. C05A Agents for treatment of hemorrhoids and anal fissures for topical use
        1. C05AA Corticosteroids, topical for treatment of hemorrhoids and anal fissures
          1. C05AA51 Hydrocortisone, combinations
Company LABORATOIRES CONFAB INC
Current status Dormant
Current status date July 19, 2021

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.